Last update:

Alzheimer's disease & dementia news

Alzheimer's disease & dementia

A protein that makes hydrogen sulfide shows potential as a therapeutic target for Alzheimer's disease

Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's disease: a protein that manufactures an important gas in the brain.

Alzheimer's disease & dementia

Brain immune cells may drive more damage in females than males with Alzheimer's

More than 7 million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's Association. The O'Banion Lab at the Del Monte Institute for Neuroscience at the University of Rochester ...

Alzheimer's disease & dementia

Menopause hormone therapy does not appear to impact dementia risk

A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia risk in postmenopausal women, in a new study led by University College London (UCL) researchers.

Neuroscience

Why a mild brain injury can trigger Alzheimer's

New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance of developing Alzheimer's disease—and the discovery is pointing to a potential strategy to prevent ...

Alzheimer's disease & dementia

Is it OK to lie to someone with dementia?

There was disagreement on social media recently after a story was published about an aged care provider creating "fake-away" burgers that mimicked those from a fast-food chain, to a resident living with dementia. The man ...

Neuroscience

How does traumatic brain injury progress to Alzheimer's disease?

A traumatic brain injury, or TBI, is caused by a contusion to the head that may result in injury to the brain. This type of injury combined with the inherited genetic risk factors can result in the accelerated development ...

Medical research

Can targeted therapies be applied to patients with Alzheimer's?

Alzheimer's disease, a debilitating brain disorder with limited treatment options, has long challenged researchers. Specifically, researchers have struggled with slowing the buildup of amyloid beta plaques, harmful clumps ...